"Choosing your family’s primary care doctor is an important decision. You want someone who offers excellent care and will take the time to build a relationship with each member of your family. Convenience, too, is a big factor."

During the past decade, Christiana Care Health System-Concord Health Center conducted 125 clinical trials. In the 10-year time frame, 125 clinical trials started and 30 clinical trials were completed, i.e. on average, 24% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 29 clinical trials were completed. i.e. 58% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christiana Care Health System-Concord Health Center" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "NRG Oncology" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christiana Care Health System-Concord Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 70 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Christiana Care Health System-Concord Health Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Invasive Breast Carcinoma" (6 trials) and "Prostate Adenocarcinoma" (6 trials). Many other conditions were trialed in "Christiana Care Health System-Concord Health Center" in a lesser frequency.

Most popular intervention types in "Christiana Care Health System-Concord Health Center" are "Drug" (99 trials), "Other" (86 trials), "Biological" (50 trials), "Procedure" (37 trials) and "Radiation" (35 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (41 trials), "Laboratory Biomarker Analysis" (39 trials), "Questionnaire Administration" (28 trials), "Nivolumab" (21 trials) and "Cisplatin" (20 trials). Other intervention names were less common.

The vast majority of trials in "Christiana Care Health System-Concord Health Center" are 105 trials for "All" genders, 13 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Christiana Care Health System-Concord Health Center". undefined are not yet recruiting, 48 are recruiting, 56 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Christiana Care Health System-Concord Health Center, 5 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Christiana Care Health System-Concord Health Center, 1 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".